The role of CD39-expressing regulatory T cells following treatment with αCD52: an effective therapeutic against central nervous system autoimmunity

被引:0
|
作者
Brass, Sara Colpitts [1 ]
Burgess, Joseph N. [1 ]
Begum-Haque, Sakhina [1 ]
Kasper, Lloyd H. [1 ]
机构
[1] Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA
来源
JOURNAL OF IMMUNOLOGY | 2018年 / 200卷 / 01期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
121.19
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Fingolimod Increases CD39-Expressing Regulatory T Cells in Multiple Sclerosis Patients
    Muls, Nathalie
    Dang, Hong Anh
    Sindic, Christian J. M.
    van Pesch, Vincent
    PLOS ONE, 2014, 9 (11):
  • [2] LF 15-0195 treatment protects against central nervous system autoimmunity by favoring the development of Foxp3-expressing regulatory CD4 T cells
    Duplan, V
    Beriou, G
    Heslan, JM
    Bruand, C
    Dutartre, P
    Mars, LT
    Liblau, RS
    Cuturi, MC
    Saoudi, A
    JOURNAL OF IMMUNOLOGY, 2006, 176 (02): : 839 - 847
  • [3] Peripheral CD39-expressing T regulatory cells are increased and associated with relapsing-remitting multiple sclerosis in relapsing patients
    Nuria Álvarez-Sánchez
    Ivan Cruz-Chamorro
    María Díaz-Sánchez
    Patricia Judith Lardone
    Juan Miguel Guerrero
    Antonio Carrillo-Vico
    Scientific Reports, 9
  • [4] Peripheral CD39-expressing T regulatory cells are increased and associated with relapsing-remitting multiple sclerosis in relapsing patients
    Alvarez-Sanchez, Nuria
    Cruz-Chamorro, Ivan
    Diaz-Sanchez, Maria
    Judith Lardone, Patricia
    Miguel Guerrero, Juan
    Carrillo-Vico, Antonio
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [5] Peripheral CD39-expressing regulatory T cell subsets play an age-dependent role in the severity of COVID-19
    Cagan, Eren
    Simsek, Abdurrahman
    Kizmaz, Muhammed Ali
    Dombaz, Fatma
    Tezcan, Gulcin
    Asan, Ali
    Demir, H. Ibrahim
    Bal, S. Haldun
    Ermis, Digdem Yoyen
    Dilektasli, Asli Gorek
    Kazak, Esra
    Akalin, E. Halis
    Oral, Haluk Barbaros
    Budak, Ferah
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 92 - 92
  • [6] Neuroprotective autoimmunity:: Naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system
    Kipnis, J
    Mizrahi, T
    Hauben, E
    Shaked, I
    Shevach, E
    Schwartz, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (24) : 15620 - 15625
  • [7] Viral infection triggers central nervous system autoimmunity via activation of CD8+ T cells expressing dual TCRs
    Qingyong Ji
    Antoine Perchellet
    Joan M Goverman
    Nature Immunology, 2010, 11 : 628 - 634
  • [8] Viral infection triggers central nervous system autoimmunity via activation of CD8+ T cells expressing dual TCRs
    Ji, Qingyong
    Perchellet, Antoine
    Goverman, Joan M.
    NATURE IMMUNOLOGY, 2010, 11 (07) : 628 - U99
  • [9] A Transgenic Model of Central Nervous System Autoimmunity Mediated by CD4+ and CD8+ T and B Cells
    Anderson, Ana C.
    Chandwaskar, Rucha
    Lee, David H.
    Sullivan, Jenna M.
    Solomon, Adam
    Rodriguez-Manzanet, Roselynn
    Greve, Bernhard
    Sobel, Raymond A.
    Kuchroo, Vijay K.
    JOURNAL OF IMMUNOLOGY, 2012, 188 (05): : 2084 - 2092
  • [10] Anti-mu CD52 treatment induces CD39+regulatory cells in the GALT and suppresses inflammatory cytokine expression within the CNS of EAE mice
    Pant, A. B.
    Wang, Y.
    Mielcarz, D.
    Mishra, M.
    Channon, J. Y.
    Telesford, K. M.
    Kasper, E. J.
    Kircher, C.
    Ochoa-Reparaz, J.
    Haque, A.
    Kasper, L. H.
    Begum-Haque, S.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 244 - 244